What is Premier Biotech?
Premier Biotech operates as a premier provider of rapid drug testing diagnostic devices, anchored by its CAP Forensic accredited laboratory based in Minneapolis, Minnesota. The company distinguishes itself through a robust service model that integrates advanced diagnostic hardware with customized screening solutions. By serving diverse verticals including criminal justice, corrections, workplace safety, and health and human services, Premier Biotech has established a critical market position. Its ability to deliver high-accuracy, rapid-turnaround results makes it an essential partner for organizations requiring stringent compliance and reliable clinical data. The firm's focus on both technological innovation and regulatory adherence provides a competitive moat in the diagnostic services landscape.
How much funding has Premier Biotech raised?
Premier Biotech has raised a total of $690K across 1 funding round:
Debt
$690K
Debt (2021): $690K with participation from PPP
Key Investors in Premier Biotech
PPP
Public-Private Partnership
What's next for Premier Biotech?
With the recent influx of capital, Premier Biotech is poised to transition into a phase of aggressive enterprise-level expansion. The strategic roadmap likely involves scaling its laboratory capacity to meet the rising demand for rapid diagnostic screening across its core sectors. Furthermore, the company is expected to leverage this investment to enhance its proprietary diagnostic technology, potentially integrating digital health platforms to streamline data reporting for its clinical and workplace clients. As the firm matures, the focus will shift toward optimizing operational efficiencies and expanding its market share in the forensic and human services domains, ensuring that its diagnostic offerings remain at the forefront of industry standards.
See full Premier Biotech company page
